Jenny Chaplin
Corporate Officer/Principal bij BELLICUM PHARMACEUTICALS, INC.
Actieve functies van Jenny Chaplin
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-2018 | - |
Loopbaan van Jenny Chaplin
Opleiding van Jenny Chaplin
| University of the Witwatersrand | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 2 |
| Zuid-Afrika | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
- Beurs
- Insiders
- Jenny Chaplin
- Ervaring
